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Abstract
Background: The novel pandemic A (H1N1) virus was first identified in Mexico in April 2009 and since then it
spread world wide over a short period of time. Although the virus infection is generally associated with mild
disease and a relatively low mortality, it is projected that mutations in specific regions of the viral genome,
especially within the receptor binding domain of the hemagglutinin (HA) protein could result in more virulent
virus stains, leading to a more severe pandemic.
Results: Here, we found that a single amino acid substitution of Asp-to-Gly at position 222 in the HA protein of
the A (H1N1) virus occurred after two passage propagation in the allantoic cavities of chicken embryonated eggs,
and this single residue variation dramatically increased the viral replication ability in MDCK cells and pathogenicity
in BALB/c mice.
Conclusions: A substitution of Asp-to-Gly at position 222 in the HA protein was prone to occur under positive
selection pressures, and this single amino acid mutation could dramatically increase the virus replication ability
in vitro and pathogenicity in vivo. Our finding offers a better understanding of the transmission and evolution of
the 2009 pandemic A (H1N1) virus and brings attention to further potentially severe influenza pandemic that may
result from cross-host evolution of the influenza viruses.
Background
On June 11, 2009, the World Health Organization raised
the global pandemic alert level to phase 6, the pandemic
phase, in response to the emergence and global spread
of a novel A (H1N1) influenza virus, which emerged in
Mexico in early 2009 [1]. The onset of the pandemic A
(H1N1) influenza virus infection has been relatively
mild, with clinical manifestations progressing from mild
upper respiratory tract illness to severe pneumonia lead-
ing to acute respiratory distress syndrome [2]. Sporadic
deaths happened in individuals with poor pre-existing
immunity to influenza viruses. However, it is projected
that mutations in the viral genome could result in more
virulent viruses, leading to a more severe pandemic.
The virulence, pathogenicity, and host range of influ-
enza viruses are determined by many factors, including
virus-specific determinants encoded within the viral gen-
ome. The HA protein is especially important in that it
main functions were receptor binding and membrane
fusion. Glaser et al. reported that a single amino acid
mutation at position 190 of the HA protein of the 1918
pandemic H1N1 influenza virus resulted in a preference
for avian receptor (a2,3Gal sialic acid) to human receptor
(a2,6Gal sialic acid) [3]. Also, the HA protein from the
1918 pandemic H1N1 switched from avian to human
receptor specificity through mutations at two positions
(Glu187Asp and Gly222Asp) [4]. In addition, the A/New
York/1/18 strain of the 1918 pandemic possessed a Gly
at position 222 and this mutation markedly affected
receptor binding, reducing a2,6 preference and increas-
ing a2,3 avidity [4]. Furthermore, a comparison of the
HA sequences from the 2009 H1N1 viruses with that of
* Correspondence: qinchuan@pumc.edu.cn
Institute of Laboratory Animal Sciences, Chinese Academy of Medical
Sciences (CAMS) & Comparative Medicine Center, Peking Union Medical
Collage (PUMC), Beijing, 100021, China
Xu et al. Virology Journal 2010, 7:325
http://www.virologyj.com/content/7/1/325
© 2010 Xu et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.the 1918 H1N1 viruses revealed a variation at residue
200, which is shown to be involved in receptor binding.
It is proposed that this Pro-to-Ser substitution causes the
relative avirulence of the 2009 H1N1 virus compared to
the 1918 H1N1 virus [5]. More recently, Xu et al.
reported that a single amino acid substitution of
Gln226Arg in the HA of a H1N1 virus strain A/Solomon
Island/3/06 resulted in the complete loss of binding to
a2,6Gal sialic acid, and concomitant loss of the virus
ability to replicate in the lower respiratory tract of ferrets
[6]. All above studies demonstrated that polymorphism
of the HA protein, especially within the receptor binding
domain, play a critical role in the binding preference and
pathogenicity of the H1N1 influenza virus.
In this study, two prototypic strains of the 2009 pan-
demic A (H1N1) influenza viruses were continuously
passaged in chicken embryonated eggs. Afterwards, wild
type and embryonated chicken eggs adaptive viruses
were compared under in vitro and in vivo conditions.
Virus replication was analyzed in MDCK cells, whereas
pathogenicity was tested in BALB/c mice model. We
hope that the results could further our understanding of
the evolutionary event of the 2009 pandemic A (H1N1)
viruses under environmental selective pressures when
cross host, and the role of viral polymorphism of the
HA protein in replication and pathogenicity of the 2009
pandemic A (H1N1) influenza virus.
Materials and methods
Viruses
A/California/04/2009 and A/California/07/2009 were the
prototypic strains of the 2009 pandemic A (H1N1) influ-
enza viruses which were collected in California, the Uni-
ted States in April 2009. Both of these two viruses were
propagated in Madin-Darby canine kidney (MDCK)
cells. The 50% tissue culture infectious dose (TCID50)
was determined by serial titration of viruses in MDCK
cells respectively, and the titers were calculated accord-
ing to the Reed-Muench method [7]. Meanwhile, these
two prototypic viruses were continuous passaged in
allantoic cavities of 10-day-old chicken embryonated
eggs, and mut-A/California/04/2009 and mut-A/California/
07/2009 strains were the second passage viral stock
propagated from the chicken embryonated eggs. All
experiments involving the viruses were conducted under
biosafety level 3 (BSL-3) conditions for both in vitro cells
infection and in vivo animal challenge, in associated with
guidelines of the World Health Organization http://www.
who.int/csr/resourse/publications/swineflu/Laboratory-
bioriskmanagement.pdf.
Genome sequencing and analysis
All eight gene segments of wild type and mutant A/
California/04/2009 and A/California/07/2009 viruses
were amplified by high fidelity PCR (KOD plus DNA
polymerase, TOYOBO). The PCR products were puri-
fied and sequenced (Invitrogen, Shanghai). Sequences of
all viruses were alignmented with CLUSTAL W (version
1.83) software.
Cells infection
MDCK cells were maintained in Dulbecco’s modified
Eagle’s medium (DMEM) (Invitrogen) supplemented
with 10% FBS. 10
2 TCID50 viruses were added to cell
monolayers in 35-mm dishes (Corning) separately. After
a 60 min adsorption at 37°C, cells were fed with 3ml
serum-free minimum essential medium containing tosyl-
sulfonyl phenylalanyl chloromethyl ketone (TPCK)-trea-
ted trypsin (0.5 μg/ml) (Sigma) and antibiotics (Sigma).
This was designated as 0 hour post infection. 100 μl
viral supernatants were harvested at 12, 24, 36, 48, 56,
72, 96 hours post infection (h.p.i) and clarified from cell
debris by centrifugation at 3,000 g for 10 min.
Hemagglutination assay
After the MDCK cells were infected with each virus, the
titers of viruses released into the cell supernatant were
evaluated by hemagglutination assay with 1% turkey ery-
throcyte cells as an indicator of virus replication in the
cells. Briefly, a 50 μl aliquot of virus sample was incu-
bated with equal volume of 1% suspension of turkey ery-
throcyte cells for 30 min at room temperature. The
hemagglutination titer was defined as the reciprocal of
highest virus dilution that hemagglutinated turkey ery-
throcyte cells.
Mice challenge
Female 5-week-old SPF level BALB/c mice (Institute of
Laboratory Animal Sciences, Beijing) were used in the
study. Mice were anesthetized and inoculated intrana-
sally with 10
6 TCID50 of each virus in a volume of 50
μl, with 23 mice per group, in which 10 mice were mon-
itored daily for signs of disease, weight loss, and mortal-
ity up to 14 days post inoculation (d.p.i). The remaining
13 mice in each group were euthanized at 5 d.p.i. and
10 lung tissues were collected separately for viral
nucleotide material quantification and pathological
investigation, whereas another 3 mice lung were col-
lected for viral titer detection. The procedures were
approved by the Institute of Animal Use and Care Com-
mittee of the Institute of Laboratory Animal Science,
Peking Union Medical College (ILAS-PC-2010-002)
Real-time PCR
Total RNA was isolated from the infected cell superna-
tants or homogenized mice lung tissues by using the
RNeasy Mini Kit (Qiagen) according to the manufac-
turer’s instructions. RNA was dissolved in 30 μld i e t h y l
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strand cDNA was produced by using random primers
with 8 μlR N Ai na2 0μl reaction mixture containing
200 U Superscript III reverse transcriptase (Invitrogen).
The Real-time quantitative PCR assays based on SYBR
Green dye were performed on StepOne PCR system
(ABI) with 2 μl cDNA in a 20 μl reaction mixture which
also containing 10 μlo f2 ×S Y B RG r e e nP C RM a s t e r
Mix (ABI), 1 μl each of 10 μM forward and reverse pri-
mers (SW-HA F786: 5’-AATAACATTAGAAG-
CAACTGG-3’,S W - H AR 9 2 0 :5 ’-AGGCTGGTGTTT-
ATRGCACC-3’), and 6 μl nuclease-free water. Thermal
cycling was done under the following conditions: 94°C
for 3 min, followed by 35 cycles of 94°C for 30 s, 58°C
for 30 s, and 72°C for 30 s. Fluorescence measurements
were taken after each cycle.
Pathological analysis
T h em o u s el u n g sw e r er e m o v ed immediately following
euthanasia, inflated, and fixed with 10% neutral buffered
formalin overnight at 4°C. Subsequently, the formalin-
preserved lung samples were embedded in paraffin and
sectioned. Serial 4-μm sections were stained with Hema-
toxylin-Eosin and examined for pathological changes.
The images were obtained on a OLYMPUS BX-50 light
microscope with 40× magnification.
Statistical analysis
Statistical analysis of the viral RNA load and titer were
performed by SPSS 11.5 software and the DUNCAN
and LSD methods were used for detection in one-way
ANOVA means.
Results
Sequences analysis of the viral genomes
The full-length sequences of the viral genomes of wild
type and egg-adaptive mutant A/California/04/2009 and
A/California/07/2009 strains were obtained by high fide-
lity PCR and sequenced. Genomic polymorphism of the
four viruses was showed in Table 1. In the HA protein,
an Asp-to-Gly substitution at position 222 simulta-
neously occurred within mut-A/California/04/2009 and
mut-A/California/07/2009 c o m p a r e dw i t hw i l dt y p eA /
California/04/2009 and A/California/07/2009. Mean-
while, a Glu-to-Gly substitution in the NP protein also
occurred in mut-A/California/07/2009 virus. Besides
these two mutations occurred between the chicken
embryonated eggs, which were derived from viruses
with corresponding wild type viruses, two variations
between the two wild type viruses also have
been noticed. Compared with A/California/04/2009, A/
California/07/2009 possessed an Ala instead of Thr at
position 197 of the HA protein, and possessed a Tyr
instead of Phe at position 351 of the NA protein. These
two variations also existed between mut-A/California/
04/2009 and mut-A/California/07/2009 viruses.
In vitro comparison of virus replication in cells
Statistical analysis of the virus replication kinetics in
MDCK cells by one-way ANOVA showed that mut-A/
California/04/2009 and mut-A/California/07/2009
viruses exhibited significant higher (P < 0.05) viral RNA
load in infected cells than wild type A/California/04/
2009 and A/California/07/2009 from 36 to 96 h.p.i, with
peak load of roughly 3-4 log higher than respective wild
type viruses. However, there were no statistical differ-
ences (P > 0.05) among viral RNA load of A/California/
04/2009 with A/California/07/2009, and mut-A/California/
04/2009 with mut-A/California/07/2009 viruses at
each time point (Figure 1A). Furthermore, the results of
hemagglutination assay in MDCK cells showed that
mut-A/California/04/2009 and mut-A/California/07/
2009 viruses also exhibited higher ability to agglutinate
turkey erythrocyte cells than the wild type viruses at 96
h.p.i (P < 0.05), whereas there were no statistical differ-
ences (P > 0.05) among the hemagglutination results at
72 h.p.i. of all viruses. All viruses were unable to aggluti-
nate turkey erythrocyte cells before 48 h.p.i (Figure 1B).
In vivo comparison of virulence in the mice model
To further compare the virulence of the wild type and
mutant viruses in vivo, we challenged BALB/c mice with
each virus intranasally to evaluate mortality, weight loss,
viral titer and RNA load in the lung tissue. The percen-
t a g e so fm i c es u r v i v i n gt h ei n f e c t i o nw e r es h o w e di n
Figure 2A. 80% of mice which were inoculated with
mut-A/California/07/2009 virus died until 14 d.p.i..
Mice infected with mut-A/California/04/2009 showed a
survival ratio of 40%, whereas the lethality rates of A/
California/04/2009 and A/California/07/2009 viruses
were reduced to 40% and 30% respectively. Meanwhile,
mut-A/California/04/2009 and mut-A/California/07/
2009 viruses caused nearly 40% body weight loss by 9 d.
p.i. when the mice started to regain the weight over the
course of the remaining observation period. However,
the body weight losses of mice which were challenged
with wild type A/California/04/2009 and A/California/
07/2009 were less than 20% (Figure 2B). To further
investigate the differences in pathogenesis of all viruses
in mice, we examined the viral RNA loads in lung tis-
sues of challenged mice. The mean viral RNA load
(copy numbers per mg ± SD) (Figure 2C) and viral titers
(TCID50 per mg ± SD) (Figure 2D) were determined on
5 d.p.i. when virus shedding reached its peak. Mice
inoculated with mut-A/California/04/2009 and mut-A/
California/07/2009 viruses resulted in 1-2 log higher
RNA copy numbers of virus in the lungs than respective
wild type viruses. Consistent with the viral RNA load
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A/California/04/2009 and mut-A/California/07/2009
exhibited 2 log higher viral titers compared with those
inoculated with the wild type viruses.
Furthermore, to examine the pathological changes in
the lungs of challenged mice, lungs were isolated on 5 d.
p.i., and serial sectioned and stained with hematoxylin
and eosin (H&E). Pathological examination revealed all
viruses replicated efficiently in the lung tissues of mice,
which all exhibited inflammatory hyperaemia,
hemorrhage, edema, and exudative pathological changes.
Pathological changes appeared in more than 85% lung
tissues of mice inoculated with mut-A/California/04/
2009 and mut-A/California/07/2009 viruses, whereas for
those mice inoculated by A/California/04/2009 and
A/California/07/2009 viruses, the lesion occurrence rate
in lung tissues is ranged from 60% to 85% (Figure 3).
Discussion
The 2009 pandemic A (H1N1) virus is generally asso-
ciated with mild disease and a relatively low mortality.
However, sporadic severe or fatal cases were reported
from time to time. Apart from individual immunity dis-
crepancy, it is projected that the high virulence and
pathogenesis of influenza strains also is caused by the
specific sequence of viral proteins and mutations
occurred in critical regions [8,9], including the external
surface glycoproteins, hemagglutinin (HA) and neurami-
nidase (NA) in relation to their interaction with sialic
acids, the viral specific receptor on host cells [3,10-12].
Meanwhile, the three polymerase proteins have also
been shown to be important virulence determinants of
H5N1 and H7N7 viruses and transmission of the 1918
H1N1 virus [10,11,13,14]. Furthermore, the two non-
structural proteins PB1-F2 [15,16] and NS1 [17] are also
i m p l i c a t e di nv i r u l e n c eo fH 5 N 1a n d1 9 1 8H 1 N 1
viruses. For the 2009 pandemic A (H1N1) virus, it is
also supposed that mutations in specific regions of the
viral genome could result in more virulent viruses, lead-
ing to a more severe pandemic.
In this study, two prototypic strains of the 2009 pan-
demic A (H1N1) influenza viruses, A/California/04/2009
and A/California/07/2009, were continuous passaged in
chicken embryonated eggs, and the replication kinetics
and pathogenecity between the embryonated chicken eggs
adaptive viruses and the corresponding wild type viruses
were compared in vitro and in vivo. We first examined the
viral replication kinetics in MDCK cells and found
enhanced replication of the mut-A/California/04/2009 and
mut-A/California/07/2009 viruses, which leading to
increased peak RNA load of toughly 3-4 log than their
wild type viruses. Meanwhile, hemagglutinating assay
Table 1 Genomic sequences alignment of the wild type and mutated A/California/04/2009 and A/California/07/2009
viruses
Viruses PB2 PB1 PA HA NP NA M2&M1 NEP&NS1
nt aa nt aa nt aa nt aa
640 197 716 222 341 114 1052 351
A/California/04/2009 - - - A Thr A Asp A Glu T Phe - -
mut-A/California/04/2009 - - - A Thr G Gly A Glu T Phe - -
A/California/07/2009 - - - G Ala A Asp A Glu A Tyr - -
mut-A/California/07/2009 - - - G Ala G Gly G Gly A Tyr - -
Figure 1 Replication kinetics of the wild type and mutated A/
California/04/2009 and A/California/07/2009 viruses in vitro. (A)
Viral RNA loads of viruses cultured in MDCK cells. Data represented
the percentage of mean viral RNA load per 100 μl of infected cell
supernatant ± standard deviation. (B) Hemagglutination assays of
viruses cultured in MDCK cells. Data represented the mean viral HA
titers per 100 μl of infected cell supernatant ± standard deviation.
* represent statistical significance at P < 0.05 (one-way ANOVA).
Xu et al. Virology Journal 2010, 7:325
http://www.virologyj.com/content/7/1/325
Page 4 of 7showed that the peak viral titers in MDCK cells were simi-
lar with the situation of viral RNA load results. On the
other hand, our in vivo experiment was conducted in
BALB/c mice model. Pronounced difference in virulence
was observed. Similarly, mut-A/California/04/2009 and
mut-A/California/07/2009 exhibited significant enhanced
virulence as compared to the wild type strains because of
higher mortality, body weight loss, viral RNA copy num-
bers and titers, and more severe pathological changes in
mice lungs tissues.
Sequence alignment results showed that there was
only one single mutation in the HA protein (Asp222Gly)
between wt- and mut- A/California/04/2009 viruses, and
two mutations respectively in the HA (Asp222Gly)
and NP (Glu114Gly) protein between wt- and mut- A/
California/07/2009 viruses. It is interesting to note that
the two embryonated eggs derived adaptive viruses
mutated at the same site and substituted by the same
amino acid in the HA protein. According to previous
report, the egg adaptation process frequently introduces
Figure 3 Pathological analysis of the lung tissues of challenged
BALB/c mice. The images were obtained on an OLYMPUS BX-50
light microscope with 40× magnification. (A) Lung tissues of mice
challenged with A/California/04/2009 virus; (B) Lung tissues of mice
challenged with A/California/07/2009 virus; (C) Lung tissues of mice
challenged with mut-A/California/04/2009 virus; (D) Lung tissues of
mice challenged with mut-A/California/07/2009 virus.
Figure 2 Virulence comparison of the wild type and mutated A/California/04/2009 and A/California/07/2009 viruses in BALB/c mice.
(A) Survival percentage of mice intranasally challenged with each virus with 10
6 TCID50 in a volume of 50 μl. (B) Body weight changes of
infected mice. Mean body weight and standard deviation were calculated as percentage of body weight compared to those at 0 d.p.i. (C) The
viral RNA loads of viruses in lung tissues of mice which euthanized at 5 d.p.i.. Data represented the mean viral RNA load per microgram of lung
tissues ± standard deviation. (D) The viral titers in lung tissues of mice which euthanized at 5 d.p.i.. Data represented the mean log TCID50 per
microgram of lung tissues.
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receptor binding and sometimes even viral antigenicity
[18-22]. Meanwhile, residue 222 was reported to locate
in the receptor binding domain of the HA protein
[23-26]. As for other HA protein structures, the receptor
binding domain is composed of three structural
elements: a 190-helix (residues 184-191), a 220-loop
(residues 218-225), and a 130-loop (residues 131-135)
[27]. We proposed that the substitution of Asp with Gly
at residue 222 of the HA protein may favor the interac-
tion with the specific receptor sialic acid a2,6Gal and
further virion entry into the host cells. Indeed, this
hypothesis has been verified by some studies. The HA
from the 1918 H1N1 pandemic switched from avian to
human receptor specificity through mutation at two
positions (Glu187Asp and Gly222Asp) [4]. In addition,
the A/New York/1/18 strain of the 1918 pandemic pos-
sessed a Gly at position 222 and this markedly affected
receptor binding, reduced a2,6 preference and increased
a2,3 avidity [4]. More recently, there has been focus on
the possible role of the mutation at position 222 of the
HA protein and its role in severe clinical outcome
[28,29]. The Asp222Gly and Asp222Asn single and
m i x e dv a r i a n t sw e r ef o u n di np a n d e m i cv i r u s e sa sw e l l
as direct sequencing from clinical specimens collected
throughout the 2009 pandemic from approximately 20
countries, including Norway, Mexico, Ukraine and the
USA. Summarized the above data, it is much likely that
Asp222Gly substitution in the HA protein may be a cri-
tical positive selection event during the virus egg ampli-
fication process and is an important virulence factor for
the 2009 pandemic A (H1N1) influenza virus. Poly-
morphism at this residue may have remarkable impact
on viral host range, replication, and pathogenicity. It is
worth noting that although the Asp222Gly mutation
currently has not been associated with severe pandemic
in humans, our data suggests that such laboratory adap-
tation of the pandemic A (H1N1) viruses from human
to chicken embryonated eggs may increase the potential
risks involved in handling with the mutant viruses.
Once they cross species and transmit from chicken back
to human, there may be another potential severe pan-
demic of influenza.
Conclusions
In summary, we found that when the 2009 pandemic A
(H1N1) influenza virus were propagated in the chicken
embryonated eggs, a substitution of Asp-to-Gly at posi-
tion 222 in the HA protein was prone to occur under
positive selection pressures, and this single amino acid
mutation could dramatically increase the virus replica-
tion ability in vitro and pathogenicity in vivo. These pre-
liminary observations, however, invite further studies
into the transmission and evolution of these viruses, and
provide new insights into the impact of genetic changes
that may have on the replication and pathogenicity of
the 2009 pandemic A (H1N1) influenza virus.
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